RecruitingNCT06095518
DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study
Sponsor
Queen Mary Hospital, Hong Kong
Enrollment
50 participants
Start Date
May 30, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
To study the correlation between novel DIC markers and thrombin generation parameters with thrombotic and hemorrhagic complications of patients on ECMO support.
Eligibility
Max Age: 80 Years
Inclusion Criteria3
- Age ≧ 18; AND
- Admitted to the mixed medical-surgical intensive care units of Queen Mary Hospital or Tuen Mun Hospital in Hong Kong; AND
- Require either veno-arterial (VA) or veno-venous (VV) extracorporeal membrane oxygenation (ECMO) support.
Exclusion Criteria4
- Patients who are on central VA-ECMO support; OR
- Patients with missing clinical data; OR
- Patients with pre-existing thromboembolism requiring long term anticoagulation prior to ECMO cannulation; OR
- Post-operative admissions
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTDIC markers and Thrombin Generation Parameters
Observation of DIC markers and thrombin generation parameters in patients with and without thrombotic and hemorrhagic complications
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06095518
Related Trials
MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
NCT0548761213 locations
Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock
NCT039480481 location
Pilot Study on HA380 Column Use in Critically Ill Patients Receiving Extracorporeal Support.
NCT061797711 location
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NCT0544085186 locations
Anticoagulation-free VV ECMO for Acute Respiratory Failure
NCT042736071 location